The gut microbiota and Type 1 Diabetes

Clinical Immunology

Volumn 159, Issue 2, 2015, Pages 143-153

  Gülden, Elke ^a   Wong, F Susan ^b   Wen, Li ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Gut microbiota; Gut permeability; Th17 cells; Treg; Type 1 Diabetes

Indexed keywords

ANTIBIOTIC AGENT; PATTERN RECOGNITION RECEPTOR; PROBIOTIC AGENT;

ACIDITY; ADAPTIVE IMMUNITY; ANTIBIOTIC THERAPY; AUTOIMMUNITY; BACTERIAL COLONIZATION; BREAST MILK; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CESAREAN SECTION; CHILD NUTRITION; CYTOSKELETON; DIET; ENVIRONMENTAL FACTOR; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; INTESTINE EPITHELIUM CELL; INTESTINE FLORA; INTESTINE MUCOSA PERMEABILITY; LACTOBACILLUS JOHNSONII; LACTOBACILLUS REUTERI; LYMPHOCYTE DIFFERENTIATION; MICROTUBULE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REVIEW; TIGHT JUNCTION; VAGINAL DELIVERY; ANIMAL; DELIVERY; DYSBIOSIS; FEMALE; IMMUNOLOGY; INTESTINE; MALE; METABOLISM; MICROBIOLOGY; MOUSE; NEWBORN; PERMEABILITY; PREGNANCY; RAT; REGULATORY T LYMPHOCYTE; TH17 CELL;

ANIMALS; DELIVERY, OBSTETRIC; DIABETES MELLITUS, TYPE 1; DIET; DYSBIOSIS; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; INFANT, NEWBORN; INSULIN-SECRETING CELLS; INTESTINES; MALE; MICE; PERMEABILITY; PREGNANCY; RATS; T-LYMPHOCYTES, REGULATORY; TH17 CELLS;

EID: 84945303447     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2015.05.013     Document Type: Review

References (104)

1. Pociot F., McDermott M.F. Genetics of type 1 diabetes mellitus. Genes Immun. 2002, 3:235-249.
2. Harjutsalo V., Sjoberg L., Tuomilehto J. Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study. Lancet 2008, 371:1777-1782.
3. Patterson C.C., Dahlquist G.G., Gyurus E., Green A., Soltesz G., Group E.S. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet 2009, 373:2027-2033.
4. Patterson C.C., Gyurus E., Rosenbauer J., Cinek O., Neu A., Schober E., Parslow R.C., Joner G., Svensson J., Castell C., Bingley P.J., Schoenle E., Jarosz-Chobot P., Urbonaite B., Rothe U., Krzisnik C., Ionescu-Tirgoviste C., Weets I., Kocova M., Stipancic G., Samardzic M., de Beaufort C.E., Green A., Dahlquist G.G., Soltesz G. Trends in childhood type 1 diabetes incidence in Europe during 1989-2008: evidence of non-uniformity over time in rates of increase. Diabetologia 2012, 55:2142-2147.
5. Visser J., Rozing J., Sapone A., Lammers K., Fasano A. Tight junctions, intestinal permeability, and autoimmunity: celiac disease and type 1 diabetes paradigms. Ann. N. Y. Acad. Sci. 2009, 1165:195-205.
6. Khashan A.S., Kenny L.C., Lundholm C., Kearney P.M., Gong T., Almqvist C. Mode of obstetrical delivery and type 1 diabetes: a sibling design study. Pediatrics 2014, 134:e806-e813.
7. Cardwell C.R., Stene L.C., Joner G., Cinek O., Svensson J., Goldacre M.J., Parslow R.C., Pozzilli P., Brigis G., Stoyanov D., Urbonaite B., Sipetic S., Schober E., Ionescu-Tirgoviste C., Devoti G., de Beaufort C.E., Buschard K., Patterson C.C. Caesarean section is associated with an increased risk of childhood-onset type 1 diabetes mellitus: a meta-analysis of observational studies. Diabetologia 2008, 51:726-735.
8. Kimpimaki T., Erkkola M., Korhonen S., Kupila A., Virtanen S.M., Ilonen J., Simell O., Knip M. Short-term exclusive breastfeeding predisposes young children with increased genetic risk of Type I diabetes to progressive beta-cell autoimmunity. Diabetologia 2001, 44:63-69.
9. Holmberg H., Wahlberg J., Vaarala O., Ludvigsson J., Group A.S. Short duration of breast-feeding as a risk-factor for beta-cell autoantibodies in 5-year-old children from the general population. Br. J. Nutr. 2007, 97:111-116.
10. Norris J.M., Barriga K., Klingensmith G., Hoffman M., Eisenbarth G.S., Erlich H.A., Rewers M. Timing of initial cereal exposure in infancy and risk of islet autoimmunity. JAMA 2003, 290:1713-1720.
11. Ziegler A.G., Schmid S., Huber D., Hummel M., Bonifacio E. Early infant feeding and risk of developing type 1 diabetes-associated autoantibodies. JAMA 2003, 290:1721-1728.
12. Brugman S., Klatter F.A., Visser J.T., Wildeboer-Veloo A.C., Harmsen H.J., Rozing J., Bos N.A. Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes?. Diabetologia 2006, 49:2105-2108.
13. Hansen C.H., Krych L., Nielsen D.S., Vogensen F.K., Hansen L.H., Sorensen S.J., Buschard K., Hansen A.K. Early life treatment with vancomycin propagates Akkermansia muciniphila and reduces diabetes incidence in the NOD mouse. Diabetologia 2012, 55:2285-2294.
14. C.Human Microbiome Project Structure, function and diversity of the healthy human microbiome. Nature 2012, 486:207-214.
15. Bach J.F. The effect of infections on susceptibility to autoimmune and allergic diseases. N. Engl. J. Med. 2002, 347:911-920.
16. Blaser M.J., Falkow S. What are the consequences of the disappearing human microbiota?. Nat. Rev. Microbiol. 2009, 7:887-894.
17. Brown C.T., Davis-Richardson A.G., Giongo A., Gano K.A., Crabb D.B., Mukherjee N., Casella G., Drew J.C., Ilonen J., Knip M., Hyoty H., Veijola R., Simell T., Simell O., Neu J., Wasserfall C.H., Schatz D., Atkinson M.A., Triplett E.W. Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes. PLoS One 2011, 6:e25792.
18. Giongo A., Gano K.A., Crabb D.B., Mukherjee N., Novelo L.L., Casella G., Drew J.C., Ilonen J., Knip M., Hyoty H., Veijola R., Simell T., Simell O., Neu J., Wasserfall C.H., Schatz D., Atkinson M.A., Triplett E.W. Toward defining the autoimmune microbiome for type 1 diabetes. ISME J. 2011, 5:82-91.
19. Dunne J.L., Triplett E.W., Gevers D., Xavier R., Insel R., Danska J., Atkinson M.A. The intestinal microbiome in type 1 diabetes. Clin. Exp. Immunol. 2014, 177:30-37.
20. de Goffau M.C., Fuentes S., van den Bogert B., Honkanen H., de Vos W.M., Welling G.W., Hyoty H., Harmsen H.J. Aberrant gut microbiota composition at the onset of type 1 diabetes in young children. Diabetologia 2014, 57:1569-1577.
21. de Goffau M.C., Luopajarvi K., Knip M., Ilonen J., Ruohtula T., Harkonen T., Orivuori L., Hakala S., Welling G.W., Harmsen H.J., Vaarala O. Fecal microbiota composition differs between children with beta-cell autoimmunity and those without. Diabetes 2013, 62:1238-1244.
22. Pozzilli P., Signore A., Williams A.J., Beales P.E. NOD mouse colonies around the world-recent facts and figures. Immunol. Today 1993, 14:193-196.
23. King C., Sarvetnick N. The incidence of type-1 diabetes in NOD mice is modulated by restricted flora not germ-free conditions. PLoS One 2011, 6:e17049.
24. Alam C., Bittoun E., Bhagwat D., Valkonen S., Saari A., Jaakkola U., Eerola E., Huovinen P., Hanninen A. Effects of a germ-free environment on gut immune regulation and diabetes progression in non-obese diabetic (NOD) mice. Diabetologia 2011, 54:1398-1406.
25. Akira S., Takeda K. Toll-like receptor signalling. Nat. Rev. Immunol. 2004, 4:499-511.
26. Wen L., Ley R.E., Volchkov P.Y., Stranges P.B., Avanesyan L., Stonebraker A.C., Hu C., Wong F.S., Szot G.L., Bluestone J.A., Gordon J.I., Chervonsky A.V. Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 2008, 455:1109-1113.
27. Valladares R., Sankar D., Li N., Williams E., Lai K.K., Abdelgeliel A.S., Gonzalez C.F., Wasserfall C.H., Larkin J., Schatz D., Atkinson M.A., Triplett E.W., Neu J., Lorca G.L. Lactobacillus johnsonii N6.2 mitigates the development of type 1 diabetes in BB-DP rats. PLoS One 2010, 5:e10507.
28. Kriegel M.A., Sefik E., Hill J.A., Wu H.J., Benoist C., Mathis D. Naturally transmitted segmented filamentous bacteria segregate with diabetes protection in nonobese diabetic mice. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:11548-11553.
29. Yurkovetskiy L., Burrows M., Khan A.A., Graham L., Volchkov P., Becker L., Antonopoulos D., Umesaki Y., Chervonsky A.V. Gender bias in autoimmunity is influenced by microbiota. Immunity 2013, 39:400-412.
30. Van Itallie C.M., Anderson J.M. Architecture of tight junctions and principles of molecular composition. Semin. Cell Dev. Biol. 2014.
31. Vetrano S., Rescigno M., Cera M.R., Correale C., Rumio C., Doni A., Fantini M., Sturm A., Borroni E., Repici A., Locati M., Malesci A., Dejana E., Danese S. Unique role of junctional adhesion molecule-a in maintaining mucosal homeostasis in inflammatory bowel disease. Gastroenterology 2008, 135:173-184.
32. Zeissig S., Burgel N., Gunzel D., Richter J., Mankertz J., Wahnschaffe U., Kroesen A.J., Zeitz M., Fromm M., Schulzke J.D. Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease. Gut 2007, 56:61-72.
33. Vogelsang H., Schwarzenhofer M., Oberhuber G. Changes in gastrointestinal permeability in celiac disease. Dig. Dis. 1998, 16:333-336.
34. Ghoshal U.C., Shukla R., Ghoshal U., Gwee K.A., Ng S.C., Quigley E.M. The gut microbiota and irritable bowel syndrome: friend or foe?. Int. J. Inflamm. 2012, 2012:151085.
35. Bosi E., Molteni L., Radaelli M.G., Folini L., Fermo I., Bazzigaluppi E., Piemonti L., Pastore M.R., Paroni R. Increased intestinal permeability precedes clinical onset of type 1 diabetes. Diabetologia 2006, 49:2824-2827.
36. Secondulfo M., Iafusco D., Carratu R., deMagistris L., Sapone A., Generoso M., Mezzogiomo A., Sasso F.C., Carteni M., De Rosa R., Prisco F., Esposito V. Ultrastructural mucosal alterations and increased intestinal permeability in non-celiac, type I diabetic patients. Dig. Liver Dis. 2004, 36:35-45.
37. Neu J., Reverte C.M., Mackey A.D., Liboni K., Tuhacek-Tenace L.M., Hatch M., Li N., Caicedo R.A., Schatz D.A., Atkinson M. Changes in intestinal morphology and permeability in the biobreeding rat before the onset of type 1 diabetes. J. Pediatr. Gastroenterol. Nutr. 2005, 40:589-595.
38. Meddings J.B., Jarand J., Urbanski S.J., Hardin J., Gall D.G. Increased gastrointestinal permeability is an early lesion in the spontaneously diabetic BB rat. Am. J. Physiol. 1999, 276:G951-G957.
39. Patel R.M., Myers L.S., Kurundkar A.R., Maheshwari A., Nusrat A., Lin P.W. Probiotic bacteria induce maturation of intestinal claudin 3 expression and barrier function. Am. J. Pathol. 2012, 180:626-635.
40. Hadjiyanni I., Li K.K., Drucker D.J. Glucagon-like peptide-2 reduces intestinal permeability but does not modify the onset of type 1 diabetes in the nonobese diabetic mouse. Endocrinology 2009, 150:592-599.
41. Lee A.S., Gibson D.L., Zhang Y., Sham H.P., Vallance B.A., Dutz J.P. Gut barrier disruption by an enteric bacterial pathogen accelerates insulitis in NOD mice. Diabetologia 2010, 53:741-748.
42. Visser J.T., Lammers K., Hoogendijk A., Boer M.W., Brugman S., Beijer-Liefers S., Zandvoort A., Harmsen H., Welling G., Stellaard F., Bos N.A., Fasano A., Rozing J. Restoration of impaired intestinal barrier function by the hydrolysed casein diet contributes to the prevention of type 1 diabetes in the diabetes-prone BioBreeding rat. Diabetologia 2010, 53:2621-2628.
43. de Kort S., Keszthelyi D., Masclee A.A. Leaky gut and diabetes mellitus: what is the link?. Obes. Rev. 2011, 12:449-458.
44. Wang W., Uzzau S., Goldblum S.E., Fasano A. Human zonulin, a potential modulator of intestinal tight junctions. J. Cell Sci. 2000, 113(Pt 24):4435-4440.
45. Groschwitz K.R., Hogan S.P. Intestinal barrier function: molecular regulation and disease pathogenesis. J. Allergy Clin. Immunol. 2009, 124:3-20. (quiz 21-22).
46. Watts T., Berti I., Sapone A., Gerarduzzi T., Not T., Zielke R., Fasano A. Role of the intestinal tight junction modulator zonulin in the pathogenesis of type I diabetes in BB diabetic-prone rats. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:2916-2921.
47. Kelly C.P., Green P.H., Murray J.A., Dimarino A., Colatrella A., Leffler D.A., Alexander T., Arsenescu R., Leon F., Jiang J.G., Arterburn L.A., Paterson B.M., Fedorak R.N., G.Larazotide Acetate Celiac Disease Study Larazotide acetate in patients with coeliac disease undergoing a gluten challenge: a randomised placebo-controlled study. Aliment. Pharmacol. Ther. 2013, 37:252-262.
48. Vaarala O., Klemetti P., Savilahti E., Reijonen H., Ilonen J., Akerblom H.K. Cellular immune response to cow's milk beta-lactoglobulin in patients with newly diagnosed IDDM. Diabetes 1996, 45:178-182.
49. Hoorfar J., Buschard K., Dagnaes-Hansen F. Prophylactic nutritional modification of the incidence of diabetes in autoimmune non-obese diabetic (NOD) mice. Br. J. Nutr. 1993, 69:597-607.
50. Funda D.P., Kaas A., Bock T., Tlaskalova-Hogenova H., Buschard K. Gluten-free diet prevents diabetes in NOD mice. Diabetes Metab. Res. Rev. 1999, 15:323-327.
51. Marietta E.V., Gomez A.M., Yeoman C., Tilahun A.Y., Clark C.R., Luckey D.H., Murray J.A., White B.A., Kudva Y.C., Rajagopalan G. Low incidence of spontaneous type 1 diabetes in non-obese diabetic mice raised on gluten-free diets is associated with changes in the intestinal microbiome. PLoS One 2013, 8:e78687.
52. Patrick C., Wang G.S., Lefebvre D.E., Crookshank J.A., Sonier B., Eberhard C., Mojibian M., Kennedy C.R., Brooks S.P., Kalmokoff M.L., Maglio M., Troncone R., Poussier P., Scott F.W. Promotion of autoimmune diabetes by cereal diet in the presence or absence of microbes associated with gut immune activation, regulatory imbalance, and altered cathelicidin antimicrobial peptide. Diabetes 2013, 62:2036-2047.
53. Wolf K.J., Daft J.G., Tanner S.M., Hartmann R., Khafipour E., Lorenz R.G. Consumption of acidic water alters the gut microbiome and decreases the risk of diabetes in NOD mice. J. Histochem. Cytochem. 2014, 62:237-250.
54. Hill C., Guarner F., Reid G., Gibson G.R., Merenstein D.J., Pot B., Morelli L., Canani R.B., Flint H.J., Salminen S., Calder P.C., Sanders M.E. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat. Rev. Gastroenterol. Hepatol. 2014, 11:506-514.
55. Karczewski J., Troost F.J., Konings I., Dekker J., Kleerebezem M., Brummer R.J., Wells J.M. Regulation of human epithelial tight junction proteins by Lactobacillus plantarum in vivo and protective effects on the epithelial barrier. Am. J. Physiol. Gastrointest. Liver Physiol. 2010, 298:G851-G859.
56. Pineiro M., Asp N.G., Reid G., Macfarlane S., Morelli L., Brunser O., Tuohy K. FAO technical meeting on prebiotics. J. Clin. Gastroenterol. 2008, 42(Suppl. 3 Pt 2):S156-S159.
57. Cani P.D., Possemiers S., Van de Wiele T., Guiot Y., Everard A., Rottier O., Geurts L., Naslain D., Neyrinck A., Lambert D.M., Muccioli G.G., Delzenne N.M. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 2009, 58:1091-1103.
58. Dominguez-Bello M.G., Costello E.K., Contreras M., Magris M., Hidalgo G., Fierer N., Knight R. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:11971-11975.
59. Martin R., Heilig G.H., Zoetendal E.G., Smidt H., Rodriguez J.M. Diversity of the Lactobacillus group in breast milk and vagina of healthy women and potential role in the colonization of the infant gut. J. Appl. Microbiol. 2007, 103:2638-2644.
60. Harmsen H.J., Wildeboer-Veloo A.C., Raangs G.C., Wagendorp A.A., Klijn N., Bindels J.G., Welling G.W. Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. J. Pediatr. Gastroenterol. Nutr. 2000, 30:61-67.
61. Rubaltelli F.F., Biadaioli R., Pecile P., Nicoletti P. Intestinal flora in breast- and bottle-fed infants. J. Perinat. Med. 1998, 26:186-191.
62. Fallani M., Young D., Scott J., Norin E., Amarri S., Adam R., Aguilera M., Khanna S., Gil A., Edwards C.A., Dore J., I.T.Other Members of the Intestinal microbiota of 6-week-old infants across Europe: geographic influence beyond delivery mode, breast-feeding, and antibiotics. J. Pediatr. Gastroenterol. Nutr. 2010, 51:77-84.
63. Catassi C., Bonucci A., Coppa G.V., Carlucci A., Giorgi P.L. Intestinal permeability changes during the first month: effect of natural versus artificial feeding. J. Pediatr. Gastroenterol. Nutr. 1995, 21:383-386.
64. Van Immerseel F., Ducatelle R., De Vos M., Boon N., Van De Wiele T., Verbeke K., Rutgeerts P., Sas B., Louis P., Flint H.J. Butyric acid-producing anaerobic bacteria as a novel probiotic treatment approach for inflammatory bowel disease. J. Med. Microbiol. 2010, 59:141-143.
65. Peng L., Li Z.R., Green R.S., Holzman I.R., Lin J. Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers. J. Nutr. 2009, 139:1619-1625.
66. Hansen C.H., Andersen L.S., Krych L., Metzdorff S.B., Hasselby J.P., Skov S., Nielsen D.S., Buschard K., Hansen L.H., Hansen A.K. Mode of delivery shapes gut colonization pattern and modulates regulatory immunity in mice. J. Immunol. 2014, 193:1213-1222.
67. Kirjavainen P.V., Gibson G.R. Healthy gut microflora and allergy: factors influencing development of the microbiota. Ann. Med. 1999, 31:288-292.
68. Peng J., Narasimhan S., Marchesi J.R., Benson A., Wong F.S., Wen L. Long term effect of gut microbiota transfer on diabetes development. J. Autoimmun. 2014.
69. Ochoa-Reparaz J., Mielcarz D.W., Ditrio L.E., Burroughs A.R., Foureau D.M., Haque-Begum S., Kasper L.H. Role of gut commensal microflora in the development of experimental autoimmune encephalomyelitis. J. Immunol. 2009, 183:6041-6050.
70. Tormo-Badia N., Hakansson A., Vasudevan K., Molin G., Ahrne S., Cilio C.M. Antibiotic treatment of pregnant non-obese diabetic (NOD) mice leads to altered gut microbiota and intestinal immunological changes in the offspring. Scand. J. Immunol. 2014.
71. Cox L.M., Blaser M.J. Antibiotics in early life and obesity. Nat. Rev. Endocrinol. 2015, 11:182-190.
72. Macpherson A.J., Harris N.L. Interactions between commensal intestinal bacteria and the immune system. Nat. Rev. Immunol. 2004, 4:478-485.
73. Wesemann D.R., Portuguese A.J., Meyers R.M., Gallagher M.P., Cluff-Jones K., Magee J.M., Panchakshari R.A., Rodig S.J., Kepler T.B., Alt F.W. Microbial colonization influences early B-lineage development in the gut lamina propria. Nature 2013, 501:112-115.
74. Ostman S., Rask C., Wold A.E., Hultkrantz S., Telemo E. Impaired regulatory T cell function in germ-free mice. Eur. J. Immunol. 2006, 36:2336-2346.
75. Round J.L., Mazmanian S.K. The gut microbiota shapes intestinal immune responses during health and disease. Nat. Rev. Immunol. 2009, 9:313-323.
76. Round J.L., Mazmanian S.K. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:12204-12209.
77. Furusawa Y., Obata Y., Fukuda S., Endo T.A., Nakato G., Takahashi D., Nakanishi Y., Uetake C., Kato K., Kato T., Takahashi M., Fukuda N.N., Murakami S., Miyauchi E., Hino S., Atarashi K., Onawa S., Fujimura Y., Lockett T., Clarke J.M., Topping D.L., Tomita M., Hori S., Ohara O., Morita T., Koseki H., Kikuchi J., Honda K., Hase K., Ohno H. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 2013, 504:446-450.
78. Arpaia N., Campbell C., Fan X., Dikiy S., van der Veeken J., deRoos P., Liu H., Cross J.R., Pfeffer K., Coffer P.J., Rudensky A.Y. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 2013, 504:451-455.
79. Emamaullee J.A., Davis J., Merani S., Toso C., Elliott J.F., Thiesen A., Shapiro A.M. Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice. Diabetes 2009, 58:1302-1311.
80. Honkanen J., Nieminen J.K., Gao R., Luopajarvi K., Salo H.M., Ilonen J., Knip M., Otonkoski T., Vaarala O. IL-17 immunity in human type 1 diabetes. J. Immunol. 2010, 185:1959-1967.
81. Lau K., Benitez P., Ardissone A., Wilson T.D., Collins E.L., Lorca G., Li N., Sankar D., Wasserfall C., Neu J., Atkinson M.A., Shatz D., Triplett E.W., Larkin J. Inhibition of type 1 diabetes correlated to a Lactobacillus johnsonii N6.2-mediated Th17 bias. J. Immunol. 2011, 186:3538-3546.
82. Ivanov I.I., Frutos Rde L., Manel N., Yoshinaga K., Rifkin D.B., Sartor R.B., Finlay B.B., Littman D.R. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 2008, 4:337-349.
83. Ivanov I.I., Atarashi K., Manel N., Brodie E.L., Shima T., Karaoz U., Wei D., Goldfarb K.C., Santee C.A., Lynch S.V., Tanoue T., Imaoka A., Itoh K., Takeda K., Umesaki Y., Honda K., Littman D.R. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009, 139:485-498.
84. Kamada N., Seo S.U., Chen G.Y., Nunez G. Role of the gut microbiota in immunity and inflammatory disease. Nat. Rev. Immunol. 2013, 13:321-335.
85. Matsuzaki T., Nagata Y., Kado S., Uchida K., Kato I., Hashimoto S., Yokokura T. Prevention of onset in an insulin-dependent diabetes mellitus model, NOD mice, by oral feeding of Lactobacillus casei. APMIS 1997, 105:643-649.
86. Calcinaro F., Dionisi S., Marinaro M., Candeloro P., Bonato V., Marzotti S., Corneli R.B., Ferretti E., Gulino A., Grasso F., De Simone C., Di Mario U., Falorni A., Boirivant M., Dotta F. Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse. Diabetologia 2005, 48:1565-1575.
87. van Belle T.L., Coppieters K.T., von Herrath M.G. Type 1 diabetes: etiology, immunology, and therapeutic strategies. Physiol. Rev. 2011, 91:79-118.
88. Herold K.C., Gitelman S., Greenbaum C., Puck J., Hagopian W., Gottlieb P., Sayre P., Bianchine P., Wong E., Seyfert-Margolis V., Bourcier K., Bluestone J.A., I.T.N.A.I.S.G.Immune Tolerance Network Treatment of patients with new onset Type 1 diabetes with a single course of anti-CD3 mAb Teplizumab preserves insulin production for up to 5years. Clin. Immunol. 2009, 132:166-173.
89. Ludvigsson J., Faresjo M., Hjorth M., Axelsson S., Cheramy M., Pihl M., Vaarala O., Forsander G., Ivarsson S., Johansson C., Lindh A., Nilsson N.O., Aman J., Ortqvist E., Zerhouni P., Casas R. GAD treatment and insulin secretion in recent-onset type 1 diabetes. N. Engl. J. Med. 2008, 359:1909-1920.
90. Ma Y., Liu J., Hou J., Dong Y., Lu Y., Jin L., Cao R., Li T., Wu J. Oral administration of recombinant Lactococcus lactis expressing HSP65 and tandemly repeated P277 reduces the incidence of type I diabetes in non-obese diabetic mice. PLoS One 2014, 9:e105701.
91. Robert S., Gysemans C., Takiishi T., Korf H., Spagnuolo I., Sebastiani G., Van Huynegem K., Steidler L., Caluwaerts S., Demetter P., Wasserfall C.H., Atkinson M.A., Dotta F., Rottiers P., Van Belle T.L., Mathieu C. Oral delivery of glutamic acid decarboxylase (GAD)-65 and IL10 by Lactococcus lactis reverses diabetes in recent-onset NOD mice. Diabetes 2014, 63:2876-2887.
92. Takiishi T., Korf H., Van Belle T.L., Robert S., Grieco F.A., Caluwaerts S., Galleri L., Spagnuolo I., Steidler L., Van Huynegem K., Demetter P., Wasserfall C., Atkinson M.A., Dotta F., Rottiers P., Gysemans C., Mathieu C. Reversal of autoimmune diabetes by restoration of antigen-specific tolerance using genetically modified Lactococcus lactis in mice. J. Clin. Invest. 2012, 122:1717-1725.
93. Talja I., Kubo A.L., Veijola R., Knip M., Simell O., Ilonen J., Vaha-Makila M., Sepp E., Mikelsaar M., Utt M., Uibo R. Antibodies to Lactobacilli and Bifidobacteria in young children with different propensity to develop islet autoimmunity. J. Immunol. Res. 2014, 2014:325938.
94. Soyucen E., Gulcan A., Aktuglu-Zeybek A.C., Onal H., Kiykim E., Aydin A. Differences in the gut microbiota of healthy children and those with type 1 diabetes. Pediatr. Int. 2014, 56:336-343.
95. Murri M., Leiva I., Gomez-Zumaquero J.M., Tinahones F.J., Cardona F., Soriguer F., Queipo-Ortuno M.I. Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study. BMC Med. 2013, 11:46.
96. Mejia-Leon M.E., Petrosino J.F., Ajami N.J., Dominguez-Bello M.G., de la Barca A.M. Fecal microbiota imbalance in Mexican children with type 1 diabetes. Sci. Rep. 2014, 4:3814.
97. Hara N., Alkanani A.K., Ir D., Robertson C.E., Wagner B.D., Frank D.N., Zipris D. Prevention of virus-induced type 1 diabetes with antibiotic therapy. J. Immunol. 2012, 189:3805-3814.
98. Roesch L.F., Lorca G.L., Casella G., Giongo A., Naranjo A., Pionzio A.M., Li N., Mai V., Wasserfall C.H., Schatz D., Atkinson M.A., Neu J., Triplett E.W. Culture-independent identification of gut bacteria correlated with the onset of diabetes in a rat model. ISME J. 2009, 3:536-548.
99. Sapone A., de Magistris L., Pietzak M., Clemente M.G., Tripathi A., Cucca F., Lampis R., Kryszak D., Carteni M., Generoso M., Iafusco D., Prisco F., Laghi F., Riegler G., Carratu R., Counts D., Fasano A. Zonulin upregulation is associated with increased gut permeability in subjects with type 1 diabetes and their relatives. Diabetes 2006, 55:1443-1449.
100. Mooradian A.D., Morley J.E., Levine A.S., Prigge W.F., Gebhard R.L. Abnormal intestinal permeability to sugars in diabetes mellitus. Diabetologia 1986, 29:221-224.
101. Damci T., Nuhoglu I., Devranoglu G., Osar Z., Demir M., Ilkova H. Increased intestinal permeability as a cause of fluctuating postprandial blood glucose levels in Type 1 diabetic patients. Eur. J. Clin. Invest. 2003, 33:397-401.
102. Kuitunen M., Saukkonen T., Ilonen J., Akerblom H.K., Savilahti E. Intestinal permeability to mannitol and lactulose in children with type 1 diabetes with the HLA-DQB1*02 allele. Autoimmunity 2002, 35:365-368.
103. Carratu R., Secondulfo M., de Magistris L., Iafusco D., Urio A., Carbone M.G., Pontoni G., Carteni M., Prisco F. Altered intestinal permeability to mannitol in diabetes mellitus type I. J. Pediatr. Gastroenterol. Nutr. 1999, 28:264-269.
104. Graham S., Courtois P., Malaisse W.J., Rozing J., Scott F.W., Mowat A.M. Enteropathy precedes type 1 diabetes in the BB rat. Gut 2004, 53:1437-1444.